Skip to main navigation Skip to search Skip to main content

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study

  • Jacob Sands
  • , Myung Ju Ahn
  • , Aaron Lisberg
  • , Byoung Chul Cho
  • , George Blumenschein
  • , Elaine Shum
  • , Elvire Pons Tostivint
  • , Yasushi Goto
  • , Kiyotaka Yoh
  • , Rebecca Heist
  • , Junichi Shimizu
  • , Jong Seok Lee
  • , Paul Baas
  • , David Planchard
  • , Maurice Pérol
  • , Enriqueta Felip
  • , Wu Chou Su
  • , Hong Zebger-Gong
  • , Lan Lan
  • , Chelsea Liu
    • Paul Howarth, Rachel Chiaverelli, Luis Paz-Ares

Research output: Contribution to journal › Article › peer-review

138   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases